Coty Inc Stock Price, News & Analysis

Coty Inc. (NYSE: COTY) has announced a cash tender offer to purchase up to $250 million of its outstanding 5.000% Senior Secured Notes due 2026. The tender offer includes a total consideration of $1,000 per $1,000 principal amount for notes tendered by the Early Tender Date of November 20, 2024. Additionally, Coty announced the full redemption of its €180.3 million 4.750% Senior Notes due 2026, scheduled for December 6, 2024. These actions align with Coty's deleveraging strategy to reduce total outstanding public debt.

Coty reported solid Q1 FY25 results with 2% reported revenue growth and 4.5% LFL growth. The company's performance was driven by strong growth in fragrances across all price points. Prestige segment revenues increased 5% reported and 7% LFL, while Consumer Beauty declined 3% reported with flat LFL growth. Gross margin expanded by 200 basis points to 65.5%. Reported operating income grew 20% to $237.8 million, while adjusted EBITDA remained flat at $360.1 million. The company maintained its FY25 outlook with expected LFL sales growth of 3-4% in H1.

Coty has released its FY24 Sustainability Report, highlighting significant environmental achievements and new commitments. The company has exceeded its 2030 Scope 1 and 2 emissions targets, achieving an 82% reduction since 2019, alongside a 65% reduction in air freight emissions. Key milestones include powering all owned facilities with 100% renewable electricity, recycling 85% of factory waste, and achieving gender balance in leadership ahead of schedule.

The company has set new ambitious targets, including reducing virgin plastic use by 60% by 2030, cutting water withdrawal by 25%, and ensuring 90% certification of fiber-based materials. Coty has also rejoined the Ellen MacArthur Foundation as a Network Member and launched sustainable packaging initiatives for key products.

Coty, a leading global beauty company, has announced preliminary Q1 results and reiterated its FY25 adjusted EBITDA outlook. Key points include:

- Q1 sales grew approximately 4-5% LFL, slightly below the prior estimate of 6% LFL
- Q2 LFL sales expected to grow moderately, with acceleration in the second half
- Q1 adjusted EBITDA expected to be roughly flat to moderately lower YoY
- FY25 adjusted EBITDA still projected to grow +9-11% YoY
- Cost reduction efforts re-accelerated to deliver savings above the initial FY25 target of $75M
- Targeting leverage close to 2.5x exiting CY24

The company noted slower growth in the U.S. market and tight inventory management by retailers, impacting sell-in versus sell-out performance in some markets.

Coty Inc. (NYSE: COTY)(Paris:COTY), a leading beauty company, is celebrating its 120th anniversary with a three-day fragrance event in Paris. The event, titled 'Coty: A Fragrance Disruptor since 1904', showcases the company's rich heritage and future vision in fragrance innovation.

Highlights include:

• Coty's revolutionary blending of synthetic molecules with natural ingredients since 1904
• Iconic scents from Coty's current portfolio
• The Olfactory Studio, demonstrating Coty's creativity and co-creation process
• Technological innovations in performance, emotion, and sustainability
• Introduction of Infiniment Coty Paris, a new fragrance leveraging cutting-edge technologies like Molecular Aura and EmoChar™

CEO Sue Nabi emphasizes Coty's position as the go-to partner for iconic scents, while Chief Brands Officer Jean Holtzmann highlights the company's expertise and passion for fragrance innovation.

Coty Inc. (NYSE: COTY) has launched its first Scientific Advisory Board to enhance skincare innovation. The board, comprising globally renowned scientific experts from diverse disciplines, held its inaugural meeting on September 24, 2024, at Coty's Skincare Research & Innovation Center of Excellence in Monaco. The board will convene twice a year to inform and inspire breakthrough innovations within Coty's R&D specialists.

CEO Sue Nabi emphasized the significance of this initiative in Coty's 120th anniversary year, stating that the experts' insights will play a pivotal role in driving skincare innovation. The board aims to align the latest science with emerging trends and consumer needs, enhancing Coty's position in skin science. Members include distinguished professionals from various fields, such as immunology, dermatology, plastic surgery, and life sciences, from locations including New York, Paris, Beijing, and Recife.

Orveda, the French biotech skincare brand, has opened its first US flagship boutique, La Maison Orveda New York City, on the Upper East Side. This 150 square foot wellness sanctuary combines luxury skincare, high-end fragrances, and curated art. The boutique features:

- Three treatment rooms for signature facials
- An event room for masterclasses and exhibitions
- A lounge area and product space
- An immersive room for Infiniment Coty Paris fragrances

The US is Orveda's leading global market, with a 54% sales increase last year. The brand plans to expand its US presence through new partnerships with Cos Bar and Nordstrom this fall.

Coty Inc. (NYSE: COTY; PARIS: COTY) has filed its annual report on Form 10-K for the fiscal year ended June 30, 2024, with the U.S. Securities and Exchange Commission (SEC) on August 20, 2024. This regulatory filing is a important document that provides comprehensive insights into the company's financial performance, business operations, and future outlook for the past fiscal year. Investors and stakeholders can access the full report on the SEC's website, offering transparency and detailed information about Coty's financial health and strategic direction.

Coty reported strong financial performance in FY24, with total net revenues growing by 10% on a reported basis and 11% on a like-for-like (LFL) basis. The company achieved double-digit growth across both its Prestige and Consumer Beauty segments, and exceeded global beauty market growth.

In FY24, Coty's Prestige net revenues rose by 13% and 14% on a reported and LFL basis, respectively, driven by strong performance in fragrances, cosmetics, and skincare. The Consumer Beauty segment saw a 6% increase in net revenues.

Coty's reported gross margin improved to 64.4% for FY24, while adjusted operating income grew by 17% to $863.4 million. However, the year saw a decrease in reported net income to $76.2 million from $495.0 million due to prior-year gains not recurring.

The company maintained its growth momentum across all regions, with significant contributions from the Americas, EMEA, and Asia Pacific. Coty's FY25 guidance aligns with its medium-term targets, expecting continued revenue growth and margin expansion.